These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17376363)

  • 1. [Risk of long-acting beta-2 agonists in asthma].
    Orriols R; Vallano A
    Med Clin (Barc); 2007 Mar; 128(9):352-4. PubMed ID: 17376363
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of long-acting beta-agonists revisited.
    Williams AA; Fung SM; Cohn JR
    Am J Med; 2011 Mar; 124(3):e11; author reply e13. PubMed ID: 21396493
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
    Ortega VE; Peters SP
    Curr Opin Pharmacol; 2010 Jun; 10(3):246-53. PubMed ID: 20452285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting inhaled beta(2)-agonist therapy in asthma.
    Kips JC; Pauwels RA
    Am J Respir Crit Care Med; 2001 Sep; 164(6):923-32. PubMed ID: 11587972
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined Analysis of Asthma Safety Trials of Long-Acting β
    Busse WW; Bateman ED; Caplan AL; Kelly HW; O'Byrne PM; Rabe KF; Chinchilli VM
    N Engl J Med; 2018 Jun; 378(26):2497-2505. PubMed ID: 29949492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LABAs in asthmatic children: highlights and new inside.
    Miraglia del Giudice M; Matera MG; Capristo C; Conte M; Santaniello F; Chinellato I; Leonardi S; Miraglia del Giudice MC; Perrone L
    Pulm Pharmacol Ther; 2013 Oct; 26(5):540-3. PubMed ID: 23583567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting β₂ agonists for asthma: a clinical paradox.
    Williams D
    Consult Pharm; 2010 Nov; 25(11):756-9. PubMed ID: 21138824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.
    Salpeter SR
    Expert Opin Drug Saf; 2010 May; 9(3):407-19. PubMed ID: 20408768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
    Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE
    Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
    Virchow C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240
    [No Abstract]   [Full Text] [Related]  

  • 12. Asthma treatment guidelines meet the real world.
    Dahlén SE; Dahlén B; Drazen JM
    N Engl J Med; 2011 May; 364(18):1769-70. PubMed ID: 21542748
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
    Kardos P
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S386-9. PubMed ID: 19941242
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing of β-adrenoceptor antagonists in asthma: an observational study.
    Morales DR; Guthrie B; Lipworth BJ; Donnan PT; Jackson C
    Thorax; 2011 Jun; 66(6):502-7. PubMed ID: 21459857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].
    Buhl R
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries for patients. What are the risks of using inhaled long-acting beta-agonist medications for the relief of asthma?
    Ann Intern Med; 2006 Jun; 144(12):I30. PubMed ID: 16785474
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies.
    Hirst C; Calingaert B; Stanford R; Castellsague J
    J Asthma; 2010 May; 47(4):439-46. PubMed ID: 20528600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA's recommendations on the use of long-acting {beta}2 agonists in the management of asthma.
    Robinson CA
    Ann Pharmacother; 2010 Oct; 44(10):1651-4. PubMed ID: 20841520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D; Glaum M; Lockey R
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.